The Drug Vehicle and Solvent N-Methylpyrrolidone Is an Immunomodulator and Antimyeloma Compound
Jake Shortt, Andy K Hsu, Benjamin P Martin, Karen Doggett, Geoffrey M Matthews, Maria A Doyle, Jason Ellul, Tina E Jockel, Daniel M Andrews, Simon J Hogg, Andrea Reitsma, David Faulkner, P Leif Bergsagel, Marta Chesi, Joan K Heath, William A Denny, Philip E Thompson, Paul J Neeson, David S Ritchie, Grant A McArthur Show all
Cell Reports | CELL PRESS | Published : 2014
The authors thank Prof. James Bradner and Prof. Constantine Mitsiades for advice and critical evaluation of experimental data. Dr. Chris Ott and Dr. Gang Lu provided assistance with IKZF assays. J.S. is supported by the Leukaemia Foundation of Australia and the Co-operative Research Centre for Biomedical Imaging Development. T.E.J. is supported by Deutsche Krebshilfe. R.W.J. is a Principal Research Fellow of the National Health and Medical Research Council (NHMRC) of Australia and supported by NHMRC Program and Project Grants, Cancer Council Victoria, the Leukaemia Foundation of Australia, and the Victorian Cancer Agency.